Berenson Cancer Center https://berensoncancercenter.com Berenson Oncology Tue, 27 Feb 2024 01:50:53 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://berensoncancercenter.com/wp-content/uploads/2023/08/cropped-favicon-32x32.png Berenson Cancer Center https://berensoncancercenter.com 32 32 JAK inhibitors Transcript https://berensoncancercenter.com/press-releases/jak-inhibitors-transcript/ https://berensoncancercenter.com/press-releases/jak-inhibitors-transcript/#respond Tue, 27 Feb 2024 01:50:38 +0000 https://berensoncancercenter.com/?p=243461 So, we’ve been working on this class of drugs [JAK inhibitors] now for about 5 or 6 years, both in … Article

]]>
https://berensoncancercenter.com/press-releases/jak-inhibitors-transcript/feed/ 0
Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study https://berensoncancercenter.com/press-releases/cancer-patients-join-oncologist-who-releases-results-of-covid-19-vaccine-cancer-study/ https://berensoncancercenter.com/press-releases/cancer-patients-join-oncologist-who-releases-results-of-covid-19-vaccine-cancer-study/#respond Wed, 09 Feb 2022 02:14:34 +0000 https://bcc.zdm/?p=1082 Article ]]> https://berensoncancercenter.com/press-releases/cancer-patients-join-oncologist-who-releases-results-of-covid-19-vaccine-cancer-study/feed/ 0 IMBCR & Emory University’s Big Discovery!!! https://berensoncancercenter.com/press-releases/imbcr-emory-universitys-big-discovery/ https://berensoncancercenter.com/press-releases/imbcr-emory-universitys-big-discovery/#respond Tue, 08 Feb 2022 02:16:29 +0000 https://bcc.zdm/?p=1084 Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against SARS-CoV-2 is unknown. Thus, … Article

]]>
https://berensoncancercenter.com/press-releases/imbcr-emory-universitys-big-discovery/feed/ 0
James R. Berenson, MD, Inc. Announces Rebranding and Changes Organization Name to Berenson Cancer Center https://berensoncancercenter.com/press-releases/james-r-berenson-md-inc-announces-rebranding-and-changes-organization-name-to-berenson-cancer-center/ https://berensoncancercenter.com/press-releases/james-r-berenson-md-inc-announces-rebranding-and-changes-organization-name-to-berenson-cancer-center/#respond Mon, 07 Feb 2022 02:17:34 +0000 https://bcc.zdm/?p=1086 New name, logo, and business unit alignment introduced as part of an extensive rebranding initiative

LOS ANGELES, Nov. 11, Article

]]>
https://berensoncancercenter.com/press-releases/james-r-berenson-md-inc-announces-rebranding-and-changes-organization-name-to-berenson-cancer-center/feed/ 0
What is Multiple Myeloma? https://berensoncancercenter.com/press-releases/what-is-multiple-myeloma/ https://berensoncancercenter.com/press-releases/what-is-multiple-myeloma/#respond Thu, 10 Jan 2019 22:10:22 +0000 http://bcc.zdm/?p=717 Survival and treatments are improving for this type of blood cancer

You don’t expect to break a rib while doing … Article

]]>
https://berensoncancercenter.com/press-releases/what-is-multiple-myeloma/feed/ 0
Combined TRAF6 Targeting and Proteasome Blockade has Anti-tumor and Anti-bone Resorptive Effects https://berensoncancercenter.com/papers/combined-traf6-targeting-and-proteasome-blockade-has-anti-tumor-and-anti-bone-resorptive-effects/ Sun, 05 Mar 2017 20:03:30 +0000 http://bcc.zdm/?p=667 Abstract

Tumor necrosis factor receptor-associated factor 6 (TRAF6) has been implicated in polyubiquitin-mediated IL-1R/TLR signaling through activation of IκB kinase

Article ]]>
Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients https://berensoncancercenter.com/papers/serum-b-cell-maturation-antigen-a-novel-biomarker-to-predict-outcomes-for-multiple-myeloma-patients/ Sun, 05 Mar 2017 20:01:21 +0000 http://bcc.zdm/?p=665 Michael Ghermezi, Mingjie Li, Suzie Vardanyan, Nika Manik Harutyunyan, Jillian Gottlieb, Ariana Berenson, Tanya M. Spektor, Claudia Andreu-Vieyra, Sophia Petraki, … Article

]]>
Outcomes in Multiple Myeloma Patients Evaluated https://berensoncancercenter.com/papers/outcomes-in-multiple-myeloma-patients-evaluated/ Sun, 05 Mar 2017 19:54:30 +0000 http://bcc.zdm/?p=663

There appears to be marked improvement in overall survival in people with multiple myeloma, according to a study involving 264

Article ]]>
Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib https://berensoncancercenter.com/papers/outcomes-of-multiple-myeloma-patients-receiving-bortezomib-lenalidomide-and-carfilzomib/ Sun, 05 Mar 2017 19:51:56 +0000 http://bcc.zdm/?p=661 ul.flex-ul { display: flex; flex-direction: row; flex-wrap: wrap; } ul.flex-ul li { margin-right: 30px; }
  • Ariana Berenson
  • Suzie Vardanyan
  • Michael 
Article ]]>
Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma https://berensoncancercenter.com/papers/soluble-b-cell-maturation-antigen-mediates-tumor-induced-immune-deficiency-in-multiple-myeloma/ Sun, 05 Mar 2017 19:48:55 +0000 http://bcc.zdm/?p=659
Eric Sanchez, Abigail Gillespie, George Tang, Morgan Ferros, Nika Manik Harutyunyan, Suzie Vardanyan, Jillian
Article ]]>